Frank Petz, Managing Director of JLL’s New England Capital Markets team tells JLL’s Investor why the Life Sciences product investment market has grown from unique, niche asset to a commodity, and what that means for real estate investors.
A representative will be in contact with you shortly.
Hear from our team leaders Frank Petz and Chris Angelone on what’s driving the group’s increased momentum in the market.
JLL Boston’s Multifamily sales team was recently ranked #1 in the market by Real Estate Alert with over $400 million in sales in the first half of 2016.
JLL Managing Director Frank Petz tells the Boston Globe what's fueling increased interest in this asset class.
131 Dartmouth trades as trophy asset.